Literature DB >> 21204888

Review article: the functional abdominal pain syndrome.

A D Sperber1, D A Drossman.   

Abstract

BACKGROUND: Functional abdominal pain syndrome (FAPS) is a debilitating disorder with constant or nearly constant abdominal pain, present for at least 6 months and loss of daily functioning. AIM: To review the epidemiology, pathophysiology and treatment of FAPS.
METHODS: A literature review using the keywords: functional abdominal pain, chronic abdominal pain, irritable bowel syndrome and functional gastrointestinal disorders.
RESULTS: No epidemiological studies have focused specifically on FAPS. Estimates of prevalence range from 0.5% to 1.7% and tend to show a female predominance. FAPS pathophysiology appears unique in that the pain is caused primarily by amplified central perception of normal visceral input, rather than by enhanced peripheral stimulation from abdominal viscera. The diagnosis of FAPS is symptom-based in accordance with the Rome III diagnostic criteria. These criteria are geared to identify patients with severe symptoms as they require constant or nearly constant abdominal pain with loss of daily function and are differentiated from IBS based on their non-association with changes in bowel habit, eating or other gut-related events. As cure is not feasible, the aims of treatment are reduced suffering and improved quality of life. Treatment is based on a biopsychosocial approach with a therapeutic patient-physician partnership at its base. Therapeutic options include central nonpharmacological and pharmacological modalities and peripheral modalities. These can be combined to produce an augmentation effect.
CONCLUSION: Although few studies have assessed functional abdominal pain syndrome or its treatment specifically, the treatment strategies outlined in this paper appear to be effective.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21204888     DOI: 10.1111/j.1365-2036.2010.04561.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

1.  Narcotic use for inflammatory bowel disease and risk factors during hospitalization.

Authors:  Millie D Long; Edward L Barnes; Hans H Herfarth; Douglas A Drossman
Journal:  Inflamm Bowel Dis       Date:  2011-07-07       Impact factor: 5.325

Review 2.  Common Functional Gastroenterological Disorders Associated With Abdominal Pain.

Authors:  Adil E Bharucha; Subhankar Chakraborty; Christopher D Sletten
Journal:  Mayo Clin Proc       Date:  2016-08       Impact factor: 7.616

Review 3.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

4.  Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial.

Authors:  Olga Brawman-Mintzer; Valerie Durkalski; Qi Wu; Joseph Romagnuolo; Evan Fogel; Paul Tarnasky; Giuseppe Aliperti; Martin Freeman; Richard Kozarek; Priya Jamidar; Mel Wilcox; Grace Elta; Kyle Orrell; April Wood; Patrick Mauldin; Jose Serrano; Douglas Drossman; Patricia Robuck; Peter Cotton
Journal:  Am J Gastroenterol       Date:  2014-01-21       Impact factor: 10.864

5.  Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy.

Authors:  Shunji Ishihara; Kazuo Yashima; Yoshinori Kushiyama; Akio Izumi; Kousaku Kawashima; Hirofumi Fujishiro; Haruhiko Kojo; Yoshinori Komazawa; Tetsuro Hamamoto; Tetsuo Yamamoto; Yuichiro Sasaki; Tatsunori Shimizu; Eiji Okamoto; Teiji Yoshimura; Koichiro Furuta; Naoya Noguchi; Hisao Tanaka; Yoshikazu Murawaki; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2012-03-30       Impact factor: 7.527

6.  Clinically Diagnosed Acute Diverticulitis in Outpatients: Misdiagnosis in Patients with Irritable Bowel Syndrome.

Authors:  George F Longstreth; Ryan S Tieu
Journal:  Dig Dis Sci       Date:  2015-10-06       Impact factor: 3.199

7.  Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents.

Authors:  Peter Przekop; Mark G Haviland; Yan Zhao; Keiji Oda; Kelly R Morton; Gary E Fraser
Journal:  J Am Osteopath Assoc       Date:  2012-11

Review 8.  Chinese Herbal Medicine for Functional Abdominal Pain Syndrome: From Clinical Findings to Basic Understandings.

Authors:  Tao Liu; Ning Wang; Li Zhang; Linda Zhong
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-05       Impact factor: 2.629

9.  Functional abdominal pain syndrome treated with Korean medication.

Authors:  Chang-Gue Son
Journal:  Integr Med Res       Date:  2013-12-17

10.  Sex-related differences of cortical thickness in patients with chronic abdominal pain.

Authors:  Zhiguo Jiang; Ivo D Dinov; Jennifer Labus; Yonggang Shi; Alen Zamanyan; Arpana Gupta; Cody Ashe-McNalley; Jui-Yang Hong; Kirsten Tillisch; Arthur W Toga; Emeran A Mayer
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.